Person:
MERİÇ HAFIZ, AYŞENUR

Profile Picture
Status
Kurumdan Ayrılmıştır
Organizational Units
OrgUnit Logo
Organizational Unit
Job Title
First Name
AYŞENUR
Last Name
MERİÇ HAFIZ
Name
Email Address
Birth Date

Filters

2010 - 201722
Reset filters

Settings

Type: Article ×

Search Results

Now showing 1 - 10 of 22
  • No Thumbnail Available
    PublicationMetadata only
    Impact of smoking on p65 nuclear factor κB, p38 mitogen-activated protein kinase, and inducible nitric oxide synthase expression levels in oral mucosa.
    (2012-07-01) Meric, AYŞENUR; OZUCER, B; GEDIKLI, O; YILDIRIM, Y; KORKUT, AY; KAHYA, V; EREN, SABRİ BAKİ; SOMAY, A; MERİÇ HAFIZ, AYŞENUR; EREN, SABRİ BAKİ
  • No Thumbnail Available
    PublicationMetadata only
    Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract.
    (2012-01-01) YAZICI, ZM; Meric, AYŞENUR; MIDI, A; ARıNC, YV; KAHYA, V; HAFıZ, G; MERİÇ HAFIZ, AYŞENUR
  • No Thumbnail Available
    PublicationMetadata only
    Does systemic steroid deficiency affect inner ear functions?
    (2015-07-01) Dogan, REMZİ; MERIC, Aysenur; Gedik, Ozge; TUGRUL, Selahattin; Eren, SABRİ BAKİ; Ozturan, ORHAN; DOĞAN, REMZI; MERİÇ HAFIZ, AYŞENUR; GEDİK, ÖZGE; TUĞRUL, SELAHATTİN; EREN, SABRİ BAKİ; ÖZTURAN, ORHAN
    Purpose: Today corticosteroids are employed for the treatment of various inner ear disorders. In this study we have investigated probable changes in hearing functions resulting from a deficiency of systemic steroid secretions.
  • No Thumbnail Available
    PublicationMetadata only
    Does adrenaline spraying over thyroidectomy area reduce bleeding?
    (2014-01-01) AYSAN, Erhan; MERIC, Aysenur; Kadioglu, HÜSEYİN; CENGIZ, Merve B.; Bozkurt, SÜLEYMAN; Memmi, NAİM; CIPE, Gokhan; MUSLUMANOGLU, Mahmut; ERSOY, YELIZ EMINE; AYŞAN, MUSTAFA ERHAN; MERİÇ HAFIZ, AYŞENUR; KADIOĞLU, HÜSEYİN; BOZKURT, SÜLEYMAN; MEMMİ, NAİM
    Background: Means to prevent and control intra-or postoperative bleeding remain a topic of utmost importance in thyroidectomy. In this randomised clinical trial, we used adrenaline spraying to see if it helps bleeding control and reduces drainage and hematoma formation after thyroidectomy. Methods: After total thyroidectomy, 1 mg/ml adrenaline solution in 10 ml saline was sprayed all over the operation area by a syringe in 40 patients of -Adrenaline (+) Group-. In the other 40 patients in -Adrenaline (-) Group-, only standart total thyroidectomy was performed. Drainage amounts of 24 hours were recorded. Results: Among 80 patients, 66 (82.5%) were female and 14 (17.5%) were male. The daily drainage amounts of the Adrenaline (+) Group were found statistically significantly lower than the Adrenaline (-) Group (p<0.05). In both of the groups, thyroid volumes were significantly correlated with the drainage amounts. -p- values were 0.008 and <0.001 in Adrenaline (+) and Adrenaline (-) Groups, respectively. Conclusions: Preliminary experience using adrenaline has been encouraging and it is useful as an adjunct to thyroid surgery in order to prevent hemorrhagia and give up drain placement. But prospective randomized trials using adequate patient numbers are still needed to validate efficacy and safety.
  • No Thumbnail Available
    PublicationMetadata only
    Unilateral osteotomies for external bony deviation.
    (2010-11-01T00:00:00Z) SENELDIR, S; KORKUT, AY; COSKUN, BAŞAK; Teker, AYŞENUR; GEDIKLI, O; KAHYA, V; MERİÇ HAFIZ, AYŞENUR
  • Thumbnail Image
    PublicationOpen Access
    Letter to the Editor regarding article by Hussein et al. doi:10.1007/s00405-014-3309-7
    (2015-10-01) Eren, SABRİ BAKİ; TUGRUL, Selahattin; OZUCER, Berke; Meric, Aysenur; Ozturan, ORHAN; EREN, SABRİ BAKİ; MERİÇ HAFIZ, AYŞENUR; ÖZTURAN, ORHAN
  • No Thumbnail Available
    PublicationMetadata only
    Antioxidant effect of pomegranate extract in reducing acute inflammation due to myringotomy.
    (2011-04-01T00:00:00Z) KAHYA, V; Meric, AYŞENUR; YAZICI, M; YUKSEL, M; MIDI, A; GEDIKLI, O; MERİÇ HAFIZ, AYŞENUR
  • No Thumbnail Available
    PublicationMetadata only
    Choroidal thickness evaluation in paediatric patients with adenotonsillar hypertrophy.
    (2017-09-01) ELBAY, AHMET; Hafiz, AYŞENUR; OZTURAN, ORHAN; YENIGUN, A; YENİGÜN, ALPER; ELBAY, AHMET; MERİÇ HAFIZ, AYŞENUR; ÖZTURAN, ORHAN
  • No Thumbnail Available
    PublicationMetadata only
    Protective Effect of Pyrrolidine Dithiocarbamate on Myringosclerosis
    (2012-01-01) Meric, Aysenur; Dogan, REMZİ; KAHYA, Volkan; Eren, SABRİ BAKİ; YUKSEL, Meral; Yegen, Gucin; Ozturan, ORHAN; MERİÇ HAFIZ, AYŞENUR; DOĞAN, REMZI; EREN, SABRİ BAKİ; ÖZTURAN, ORHAN
    Objective: Myringotomy is most often used to treat recurrent acute otitis media and chronic effusion otitis media. The most common sequela of myringotomy is myringosclerosis. It has recently been shown that the development of myringosclerosis after myringotomy occurs concomitantly with an increased concentration of reactive oxygen species in the middle-ear cavity and an inflammatory reaction in the tympanic membrane. To assess the effect of pyrrolidine dithiocarbamate on acute inflammation due to myringotomy.
  • Thumbnail Image
    PublicationOpen Access
    Factors influencing the longevity and replacement frequency of Provox voice prostheses.
    (2015-11-01) OZKUL, MH; Meric, AYŞENUR; TUGRUL, SELHATTİN; EREN, SABRİ BAKİ; YENIGUN, A; YENİGÜN, ALPER; EREN, SABRİ BAKİ; TUĞRUL, SELAHATTİN; MERİÇ HAFIZ, AYŞENUR
    INTRODUCTION This study aimed to assess the factors that influence the longevity and replacement frequency of Provox voice prostheses following their placement. METHODS The medical records of 27 patients who received Provox voice prostheses after total laryngectomy and attended follow-up regularly between 1998 and 2012 were retrospectively reviewed. The success rate of the Provox voice prostheses (i.e. whether speech was achieved), quality of speech achieved, number and type of complications encountered, frequency of prostheses replacement and reasons for prostheses replacements were evaluated. RESULTS All 27 patients were men and their mean age was 63.0 (range 43–78) years. The mean follow-up period was 60.3 (range 1–168) months. Fluent and understandable speech was achieved in 85.0% of the patients. The mean duration before prosthesis replacement had to be performed was 17.1 (range 1–36) months. The most frequent complication was fluid leakage through the prosthesis. There was a strong positive correlation of 77.1% between the longevity of prostheses and postoperative follow-up duration (r = 0.771; p < 0.01). CONCLUSION The voice prosthesis is a tool that can be delivered in a practical fashion and replaced easily with no serious complications. It is a means by which speech can be restored, with a high success rate, after total laryngectomy. In the present study, we found that postoperative follow-up duration was the most important factor influencing the longevity of the Provox voice prosthesis.